The tendinopathy psoriatic arthritis
The tendinopathy psoriatic arthritis Tendinopathy in psoriatic arthritis is an often overlooked but significant aspect of this complex autoimmune condition. Psoriatic arthritis (PsA) affects approximately 30% of individuals with psoriasis, a chronic skin disease characterized by red, scaly patches. While joint inflammation and skin symptoms are the hallmark features, extra-articular manifestations such as tendinopathy can markedly influence disease severity and patient quality of life.
Tendinopathy refers to a spectrum of tendon disorders characterized by pain, swelling, and impaired function. Unlike tendinitis, which involves acute inflammation, tendinopathy often signifies a chronic degenerative process. In the context of psoriatic arthritis, tendinopathy manifests as painful, thickened tendons and their sheaths, most commonly affecting the Achilles tendon, the entheses (where tendons insert into bone), and other small tendons around the fingers and toes. This involvement reflects the enthesitis component of PsA, which is inflammation at the sites where tendons or ligaments attach to bone. The tendinopathy psoriatic arthritis
The tendinopathy psoriatic arthritis The pathogenesis of tendinopathy in psoriatic arthritis is multifaceted. It involves immune-mediated inflammation, mechanical stress, and degenerative changes. The cytokine milieu in PsA, especially elevated levels of tumor necrosis factor-alpha (TNF-α) and interleukins, plays a central role in promoting enthesitis and tendinopathy. These inflammatory mediators lead to tissue degeneration, collagen breakdown, and abnormal repair processes, resulting in the characteristic symptoms and structural changes seen in affected tendons.
Clinically, tendinopathy in PsA can be challenging to diagnose because its symptoms overlap with other musculoskeletal conditions. Patients often report localized pain, stiffness, and swelling that worsens with activity. Physical examination may reveal tenderness over the affected tendons and entheses, as well as swelling or thickening. Imaging studies, particularly ultrasound and MRI, are invaluable for confirming tendinopathic changes, revealing thickened tendons, hypoechoic areas indicating degeneration, and increased blood flow suggestive of ongoing inflammation. The tendinopathy psoriatic arthritis
The tendinopathy psoriatic arthritis Management of tendinopathy in psoriatic arthritis involves a combination of pharmacological and non-pharmacological strategies. Disease-modifying antirheumatic drugs (DMARDs), especially biologics targeting TNF-α, have demonstrated efficacy in reducing both joint and enthesial inflammation. These agents can improve tendon and entheseal symptoms by controlling underlying immune activity. Non-steroidal anti-inflammatory drugs (NSAIDs) are often used for symptomatic relief, although their long-term use must be balanced against potential side effects.
Physical therapy also plays a vital role, emphasizing tailored exercises, stretching, and activity modification to reduce mechanical stress on tendons. In some cases, local corticosteroid injections may provide temporary relief, but repeated injections are generally avoided to prevent tendinous weakening. Emerging treatments like platelet-rich plasma (PRP) injections are under investigation, aiming to promote tissue regeneration.
Early recognition and targeted treatment of tendinopathy in psoriatic arthritis are crucial to prevent progression to tendon rupture or functional impairment. Understanding the interplay between inflammation and degenerative changes in tendons can help clinicians develop comprehensive management plans, ultimately improving patient outcomes.
In summary, tendinopathy in psoriatic arthritis is a complex condition rooted in immune-mediated inflammation affecting tendons and entheses. Its recognition is essential for comprehensive disease management, emphasizing the importance of multidisciplinary approaches that combine pharmacological control with physical therapy. The tendinopathy psoriatic arthritis
